GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

NCT01147029 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

35

Enrollment

OTHER

Sponsor class

Stopped Sponsor Decision

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: angiogenesis inhibitor GSAO
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: dynamic contrast-enhanced magnetic resonance imaging

Sponsor

Cancer Research UK